News Headlines Article

F.D.A. Weighs More Penalties in Drug Recall
New York Times

The Johnson & Johnson unit that recalled millions of bottles of liquid children’s Tylenol and other pediatric medicines last month may face criminal penalties, product seizures or other sanctions, an official from the Food and Drug Administration said Thursday. The agency is considering further actions against McNeil Consumer Healthcare, the Johnson & Johnson unit, after a pattern of violations in manufacturing and quality control practices led to a number of recent recalls, Dr. Joshua M. Sharfstein, the F.D.A.’s principal deputy commissioner, said at a Congressional hearing on Thursday.

Commands